Rotigotine
Back to searchMolecule Structure
Scientific Name
Rotigotine
Description of the Drug
Rotigotine is a non-selective dopamine agonist used for the treatment of Parkinson’s Disease and Restless Leg Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05271
http://www.drugbank.ca/drugs/DB05271
Brand Name(s)
Neupro
Company Owner(s)
Ucb Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1088585 | |
| PharmGKB | PA166165149 | |
| DrugBank | DB05271 | |
| PubChem: Thomson Pharma | 14752454 | 14752455 |
| PubChem | 59227 | |
| LINCS | LSM-45883 | |
| Nikkaji | J285.097D | |
| BindingDB | 50123626 | |
| EPA CompTox Dashboard | DTXSID5046772 | |
| DrugCentral | 2407 | |
| Brenda | 256261 | |
| ChemicalBook | CB81001679 | |
| Guide to Pharmacology | 941 | |
| rxnorm | ROTIGOTINE | NEUPRO |
| PubChem: Drugs of the Future | 12014593 | |
| ChEBI | 135351 | |
| ZINC | ZINC000000004028 |
